Preliminary SARS-CoV-2 protease inhibitor shows efficacy in mice
Using X-ray crystallography, researchers have revealed the structure of the SARS-CoV-2 main protease, designing an inhibitor to bind to this target and prevent viral replication.
List view / Grid view
Using X-ray crystallography, researchers have revealed the structure of the SARS-CoV-2 main protease, designing an inhibitor to bind to this target and prevent viral replication.
Scientists have created an artificial protein able to recognise and bind cell surface carbohydrates with high affinity and selectivity.
A new study has used several imaging techniques to characterise C. diff toxins, which could help to design drugs to combat infections from the bacteria.
Chemical crosslinking coupled with mass spectrometry (XL-MS) has been used for many years to study protein structure and function. However, recent advances in MS technology, as well as crosslinking reagents and data analysis tools, mean the technique has truly come of age. Here, Albert JR Heck, Alexander Makarov, Henning Urlaub…
The imaging equipment, European XFEL, is said to mark a new age of protein movie-making and enables enzymes involved in disease to be observed in real-time.
A report from scientists at the Moscow Institute of Physics and Technology highlights the advantages and disadvantages of serial femtosecond X-ray crystallography. This article investigates the review, focusing on its role in drug development.
A study by researchers at the Institute for Research in Biomedicine has been the first to achieve stable simulations of DNA crystals...
Study overturns previous ideas about enzyme linked to many illnesses
Researchers have uncovered the architecture of the spindle pole body in yeast...
Scientists offer important information for understanding de novo DNA methlylation...
Crystal structure of the dopamine 2 receptor bound to an antipsychotic drug provides a much-needed discovery in the quest to create effective drugs with fewer side effects...
Scientists at The Scripps Research Institute (TSRI) have discovered the workings of the first promising treatment for Marburg virus, a pathogen with the same pandemic potential as Ebola virus.
Scientists have investigated a key protein used in drug design and discovered dynamic structural features that may lead to new ways to target diseases...
Researchers have used a multi-modal integrated approach to develop potential new anti-Chagas therapies...
This In-Depth Focus explores current uses and future development in mass spectrometry imaging for bringing new drugs to market...